Johnson & Johnson buy StockNews.com
Start price
25.01.25
/
50%
€139.52
Target price
25.01.26
-
Performance (%)
30.06%
Price
12.12.25
€180.28
Summary
This prediction is currently active. With a performance of 30.06% the BUY prediction by StockNews_com is a big success. A total of €1.19 was paid as dividends for this prediction. This prediction currently runs until 25.01.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Johnson & Johnson | 4.004% | 4.004% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by StockNews_com for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for JNJ provided by MarketBeat